ADA 83rd Scientific Sessions Final Program - 340

AMERICAN DIABETES ASSOCIATION
INTEGRATED PHYSIOLOGY-LIVER
1556‑P Hepatic AMP‑Activated Protein Kinase Governs Adaptations in Liver Glucose Fluxes and Lipid
Homeostasis in Response to Exercise Training in Mice
CURTIS C. HUGHEY, DEANNA BRACY, LOUISE LANTIER, MARC FORETZ, BENOIT VIOLLET, DAVID
WASSERMAN, Minneapolis, MN, Nashville, TN, Paris, France
1557‑P Ctcfl Is a Fasting‑Induced Epigenetic Regulator of Lipid Metabolism and Ketogenesis in the
Liver
VISSARION EFTHYMIOU, LINDSAY POULOS, LEON STRAUB, VALERIE NAVARRETE, BERKCAN OZTURK,
SORAVIS OSATAPHAN, JEREMY I. CHIMENE-WEISS, MARY-ELIZABETH PATTI, Boston, MA, Dallas, TX,
Brookline, MA
1558‑P The Mitochondrial Calcium Uniporter Regulates Hepatic Mitochondrial Oxidation and
Intracellular Redox In Vivo
TRACI E. LAMOIA, BRANDON T. HUBBARD, MATEUS GUERRA, RUSSELL GOODMAN, MICHAEL H.
NATHANSON, GERALD I. SHULMAN, Boston, MA, New Haven, CT
1559‑P Glucagon Receptor-Mediated Improvements in Glycemia Are Dependent on Agonist
Pharmacodynamics
SHELLY NASON, TEAYOUN KIM, JESSICA ANTIPENKO, BIN YANG, RICHARD DIMARCHI, KIRK M.
HABEGGER, Birmingham, AL Indianapolis, IN, Bloomington, IN
1560‑P Combining Glucagon with Insulin Can Lessen the Hypoglycemic Potential of Insulin
GUILLAUME KRAFT, MELANIE SCOTT, MARTA S. SMITH, BEN FARMER, DALE S. EDGERTON, ALAN D.
CHERRINGTON, Nashville, TN
1561‑P Dietary Proteins Impact Glucose Tolerance and Hepatic Insulin Resistance in Mice through
Modulation of the Urea Cycle
FRÉDÉRIC BÉGIN, ALEXANDRE CARON, ANDRE MARETTE, Québec, QC, Canada
1562‑P Hepatic ChREBP‑β Overexpression Enhances Peripheral Glucose and Lipid Homeostasis
Independently of FGF21
SARAH HANNOU, ASHOT SARGSYAN, WENXIN TONG, JIE AN, CHRISTOPHER B. NEWGARD, INNA
ASTAPOVA, MARK A. HERMAN, Houston, TX, Durham, NC
1563‑P Hepatic PHD3 Stimulates Gluconeogenesis and Aggravates Hyperglycemia and Type 2 Diabetes
by Hydroxylating CRTC2 at Pro129 and Pro615
YAQIAN XUE, AOYUAN CUI, SHUANG WEI, FENGGUANG MA, ZHENGSHUAI LIU, XIA FANG, WENJING LI,
YUXIAO LIU, GENXIANG CAI, WEITONG SU, JIUXIANG ZHAO, CHENLIN GAO, JIAN WEN, YONG XU,
WENGUANG FU, JING C. FANG, YU LI, Shanghai, China, Luzhou, China, Qingdao, China
1564‑P Impaired Insulin Secretion Increases Glucagon Action on the Liver
ALESSIO TONELLO, MARCELLO C. LAURENTI, CLAUDIO COBELLI, ADRIAN VELLA, CHIARA DALLA MAN,
Rochester, MN, Padova, Italy
1565‑P Relationship between Glycemic Control, Body Weight, and Nonalcoholic Fatty Liver Disease
in Patients with Type 1 Diabetes
SHILTON E. DHAVER, TAREQ SALAH, MARWA AL-BADRI, KARIM KIBAA, ABDELRAHMAN KHATER, RYAN
MCCARRAGHER, FATIMAH AL-ROOMI, LILY DEMATTOS, OSAMA HAMDY, Boston, MA
1566‑P The TM6SF2 rs58542926 Polymorphism Dissociates Hepatocellular Lipids from Insulin
Resistance in Recent‑Onset Type 2 Diabetes
KÁLMÁN BÓDIS, MARIA BOMBRICH, MARTIN SCHÖN, BIRGIT KNEBEL, OANA P. ZAHARIA, GIDON J.
BÖNHOF, YANISLAVA KARUSHEVA, YULIYA KUPRIYANOVA, JORG KOTZKA, RAINER GUTHOFF, VERA
SCHRAUWEN-HINDERLING, HADI AL-HASANI, VOLKER BURKART, JULIA SZENDROEDI, ROBERT
WAGNER, DANIEL F. MARKGRAF, MICHAEL RODEN, Düsseldorf, Germany, Heidelberg, Germany, Biberach,
Germany
1567‑P Hepatic ALKBH5 Regulation of Glucose and Lipid Metabolism
KRISTIE AAMODT, MADISON POLAY, VALERIA R. SALERNO GONZALES, ROHIT KULKARNI, Boston, MA
1568‑P Identification of Stage‑Specific Hepatocytes That Contribute to Nonalcoholic Steatohepatitis
Progression
YANG XIAO, KUN ZHU, YIFAN LIU, MITCHELL A. LAZAR, Philadelphia, PA
340
Obesity/Integrated Physiology
POSTERS

ADA 83rd Scientific Sessions Final Program

Table of Contents for the Digital Edition of ADA 83rd Scientific Sessions Final Program